A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer-Reference-Cited by-同舟云学术

A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer

Published:2021-07 Issue: Volume:69 Page:103481
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Wang Xiangxue^ORCID,Bera Kaustav,Barrera Cristian,Zhou Yu,Lu Cheng,Vaidya Pranjal,Fu Pingfu,Yang Michael,Schmid Ralph Alexander,Berezowska Sabina,Choi Humberto,Velcheti Vamsidhar,Madabhushi Anant

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference40 articles.

1. Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer;Arriagada;J Clin Oncol,2010

2. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl J Med,2004

3. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer;Winton;N Engl J Med,2005

4. Spatial architecture and arrangement of tumor-infiltrating lymphocytes for predicting likelihood of recurrence in early-stage non-small cell lung cancer;Corredor;Clin Cancer Res,2019

5. Feature driven local cell graph (FeDeG): predicting overall survival in early stage lung cancer;Lu,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Label-free characterization of pathological changes in the portal area of liver fibrosis tissue using multiphoton imaging and quantitative image analysis;Journal of Physics D: Applied Physics;2024-09-05

2. Prognostic Analysis Combining Histopathological Features and Clinical Information to Predict Colorectal Cancer Survival from Whole-Slide Images;Digestive Diseases and Sciences;2024-06-05

3. Value of adjuvant chemotherapy for patients with pT2N0M0 non‐small cell lung cancer receiving radical resection;Thoracic Cancer;2023-12-14

4. Artificial Intelligence–Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study;Journal of Thoracic Oncology;2023-12

5. Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer;npj Precision Oncology;2023-06-01